Literature DB >> 25016157

Synthesis and σ receptor affinity of regioisomeric spirocyclic furopyridines.

Kengo Miyata1, Dirk Schepmann2, Bernhard Wünsch3.   

Abstract

In order to investigate systematically the effect of the position of the pyridine N-atom on the σ1 receptor affinity four regioisomeric furopyridines 2a-d were synthesized and pharmacologically evaluated. The key steps of the synthesis comprise bromine/lithium exchange at regioisomeric bromopyridinecarbaldehyde acetals 7a-d, subsequent addition to 1-benzylpiperidin-4-one and cyclization. The regioisomeric acetals 7a-d were obtained either by o-metalation of bromopyridines 5b and 5c or by oxidation of bromopicolines 3a and 3d. In radioligand binding studies the regioisomeric furopyridines 2a-d showed 7- to 12-fold lower σ1 affinity than the benzofuran analog 1. The reduced σ1 affinity of the furopyridines 2a-d is explained with the reduced electron density of the pyridine ring. Since the four regioisomeric furopyridines show almost the same σ1 affinity (Ki = 4.9-10 nM), a directed interaction of the pyridine N-atom with the receptor protein can be excluded.
Copyright © 2014 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Furopyridines; Regioisomers; Spirocyclic piperidines; Structure affinity relationships; σ(1) receptor ligands

Mesh:

Substances:

Year:  2014        PMID: 25016157     DOI: 10.1016/j.ejmech.2014.06.073

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  8 in total

1.  Propellanes as Rigid Scaffolds for the Stereodefined Attachment of σ-Pharmacophoric Structural Elements to Achieve σ Affinity.

Authors:  Héctor Torres-Gómez; Constantin Daniliuc; Dirk Schepmann; Erik Laurini; Sabrina Pricl; Bernhard Wünsch
Journal:  Int J Mol Sci       Date:  2021-05-26       Impact factor: 5.923

2.  Synthesis and receptor binding of thiophene bioisosteres of potent GluN2B ligands with a benzo[7]annulene-scaffold.

Authors:  Sören Baumeister; Dirk Schepmann; Bernhard Wünsch
Journal:  Medchemcomm       Date:  2019-01-10       Impact factor: 3.597

3.  Enantiomerically Pure Quinoline-Based κ-Opioid Receptor Agonists: Chemoenzymatic Synthesis and Pharmacological Evaluation.

Authors:  Benedikt Martin; Dirk Schepmann; Freddy A Bernal; Thomas J Schmidt; Tao Che; Karin Loser; Bernhard Wünsch
Journal:  ChemMedChem       Date:  2020-07-02       Impact factor: 3.466

4.  Synthesis and Pharmacological Evaluation of Fluorinated Quinoxaline-Based κ-Opioid Receptor (KOR) Agonists Designed for PET Studies.

Authors:  Giovanni Tangherlini; Frederik Börgel; Dirk Schepmann; Samuel Slocum; Tao Che; Stefan Wagner; Katrin Schwegmann; Sven Hermann; Nadine Mykicki; Karin Loser; Bernhard Wünsch
Journal:  ChemMedChem       Date:  2020-09-01       Impact factor: 3.466

5.  Novel Highly Potent and Selective Sigma1 Receptor Antagonists Effectively Block the Binge Eating Episode in Female Rats.

Authors:  Carlo Cifani; Emanuela Micioni Di Bonaventura; Luca Botticelli; Fabio Del Bello; Gianfabio Giorgioni; Pegi Pavletić; Alessandro Piergentili; Wilma Quaglia; Alessandro Bonifazi; Dirk Schepmann; Bernhard Wünsch; Giulio Vistoli; Maria Vittoria Micioni Di Bonaventura
Journal:  ACS Chem Neurosci       Date:  2020-09-21       Impact factor: 4.418

6.  Synthesis of Aminoethyl-Substituted Piperidine Derivatives as σ1 Receptor Ligands with Antiproliferative Properties.

Authors:  Catharina Holtschulte; Frederik Börgel; Stefanie Westphälinger; Dirk Schepmann; Gianluca Civenni; Erik Laurini; Domenico Marson; Carlo V Catapano; Sabrina Pricl; Bernhard Wünsch
Journal:  ChemMedChem       Date:  2022-02-09       Impact factor: 3.540

7.  Synthesis and σ receptor affinity of spiro[[2]benzopyran-1,1'-cyclohexanes] with an exocyclic amino moiety in the 3'-position.

Authors:  Elisabeth Kronenberg; Frauke Weber; Dirk Schepmann; Bernhard Wünsch
Journal:  RSC Med Chem       Date:  2020-12-09

8.  [2.2]Paracyclophane-Based TCN-201 Analogs as GluN2A-Selective NMDA Receptor Antagonists.

Authors:  Remya Rajan; Dirk Schepmann; Ruben Steigerwald; Julian A Schreiber; Ehab El-Awaad; Joachim Jose; Guiscard Seebohm; Bernhard Wünsch
Journal:  ChemMedChem       Date:  2021-08-03       Impact factor: 3.466

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.